전이암 환자의 예후 판단 인자로서 생체전기 임피던스 분석을 이용한 위상각의 역할
Phase Angle Using Bioelectrical Impedance Analysis for Predicting Survival in Patients with Metastatic Cancer
4
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: The aim of this study was to identify the validity of phase angle as a prognostic factor for survival in patients with metastatic cancer. Methods: Data of patients with metastatic cancer who visited the Korean medicine cancer center at Kyung Hee University Hospital in Gangdong from April 2016 to February 2018 were collected for this study. The values of phase angle (PhA) and blood hemoglobin (Hb), C-reactive protein (CRP), and serum albumin levels were also investigated by bioelectrical impedance analysis (BIA). Results: In total, 86 patients were analyzed. The cut-off value of the phase angle was determined as 5.0. Univariate and multivariate analysis revealed that phase angle (HR 3.15, 95% CI 1.79-5.54) and CRP (HR 2.15, 95% CI 1.24-3.73) predicted survival with statistical significance. The median overall survival of the low PhA group (PhA≤5.0) was 1.8 months (95% CI 0.6-2.9 months) and 7.2 months (95% CI 5.2-9.2 months) in the high PhA group (PhA>5.0)(p<0.001). Conclusions: The phase angle could be an independent prognostic factor for patients with metastatic cancer. Further research is required to confirm these findings and their correlation with other indexes.
Abstract
Objectives: The aim of this study was to identify the validity of phase angle as a prognostic factor for survival in patients with metastatic cancer. Methods: Data of patients with metastatic cancer who visited the Korean medicine cancer center at Kyung Hee University Hospital in Gangdong from April 2016 to February 2018 were collected for this study. The values of phase angle (PhA) and blood hemoglobin (Hb), C-reactive protein (CRP), and serum albumin levels were also investigated by bioelectrical impedance analysis (BIA). Results: In total, 86 patients were analyzed. The cut-off value of the phase angle was determined as 5.0. Univariate and multivariate analysis revealed that phase angle (HR 3.15, 95% CI 1.79-5.54) and CRP (HR 2.15, 95% CI 1.24-3.73) predicted survival with statistical significance. The median overall survival of the low PhA group (PhA≤5.0) was 1.8 months (95% CI 0.6-2.9 months) and 7.2 months (95% CI 5.2-9.2 months) in the high PhA group (PhA>5.0)(p<0.001). Conclusions: The phase angle could be an independent prognostic factor for patients with metastatic cancer. Further research is required to confirm these findings and their correlation with other indexes.
참고문헌 (21)
- Stone CA, "Prospective validation of the palliative prognostic index in patients with cancer", J Pain Symptom Manage, 35(6), pp.617~622 (2008)[DOI]
- Pearlman RA, "Inaccurate predictions of life expectancy: dilemmas and opportunities", Arch Intern Med, 148(12), pp.2537~2538 (1988)[DOI]
- Lamont EB, "Physician factors in the timing of cancer patient referral to hospice palliative care", Cancer, 94(10), pp.2733~2737 (2002)[DOI]
- 이인철, "말기 암 환자 여명 예측 지수의 우리나라 적용 -일개 종합병원 호스피스 입원환자 대상의 전향적 연구-", Korean Journal of Family Medicine, 28(9), pp.682~689 (2007), 대한가정의학회
- Perez Camargo DA, "Phase Angle of Bioelectrical Impedance Analysis as Prognostic Factor in Palliative Care Patients at the National Cancer Institute in Mexico", Nutr Cancer, 69(4), pp.601~606 (2017)[DOI]
- Gupta D, "Bioelectrical impedance phase angle as a prognostic indicator in advanced pancreatic cancer", Br J Nutr, 92(6), pp.957~962 (2004)[DOI]
- Gupta D, "Bioelectrical impedance phase angle as a prognostic indicator in breast cancer", BMC Cancer, 8, pp.249~ (2008)[DOI]
- Gupta D, "Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer", Am J Clin Nutr, 80(6), pp.1634~1638 (2004)[DOI]
- Castanho IA, "Relationship between the phase angle and volume of tumours in patients with lung cancer", Ann Nutr Metab, 62(1), pp.68~74 (2013)[DOI]
- 이소연, "The Association between Phase Angle of Bioelectrical Impedance Analysis and Survival Time in Advanced Cancer Patients: Preliminary Study", Korean Journal of Family Medicine, 35(5), pp.251~256 (2014), 대한가정의학회
- Edge SB, "The American joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM", Ann Surg Oncol, 17(6), pp.1471~1474 (2010)[DOI]
- Oken MM, "Toxicity and response criteria of the Eastern Cooperative Oncology Group", Am J Clin Oncol, 5(6), pp.649~655 (1982)[DOI]
- Kyle UG, "Fat-free and fat mass percentiles in 5225 healthy subjects aged 15 to 98 years", Nutrition, 17(7-8), pp.534~541 (2001)[DOI]
- Llames L, "Values of the phase angle by bioelectrical impedance; nutritional status and prognostic value", Nutr Hosp, 28(2), pp.286~295 (2013)
- Jun MH, "Glucose-independent segmental phase angles from multi-frequency bioimpedance analysis to discriminate diabetes mellitus", Scientific Reports, 8, pp.648~ (2018)[DOI]
- Morita T, "The palliative prognostic index: a scoring system for survival prediction of terminally ill cancer patients", Support Care Cancer, 7(3), pp.128~133 (1999)[DOI]
- 손효림, "말기 암 환자의 생존기간 예측: 혈액학 검사와 PPI에 대한 전향적 연구", 대한내과학회지, 81(3), pp.359~365 (2011), 대한내과학회
- Zhang J, "MELD scores and child-puh classifications predict the outcomes of ERCP in cirrhotic patients with choledocholithiasis; a retrospective cohort study", Medicine, 94(3), pp.1~6 (2015)
- Te Riele RJLM, "Influence of anemia and BMI on prognosis of laryngeal squamous cell carcinoma: Development of an updated prognostic model", Oral Oncol, 78, pp.25~30 (2018)[DOI]
- Nazoe T, "Glasgow Prognostic Score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma", Int Surg, 99(5), pp.512~517 (2014)[DOI]
- Pantano Nde P, "Validation of the Modified Glasgow Prognostic Score in Advanced Cancer Patients Receiving Palliative Care", J Pain Symptom Manage, 51(2), pp.270~277 (2016)[DOI]